ReviewArchives of virology2012
Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine.
Marc H V Van RegenmortelPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this papercites it